Kukje Pharma Co., Ltd. (KRX:002720)

Kukje Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	88,577	87,559	103,034	119,890	106,115	112,861
Market Cap Growth	-7.55%	-15.02%	-14.06%	12.98%	-5.98%	-36.19%
Enterprise Value	108,271	99,924	124,008	140,751	127,215	143,804
Last Close Price	4350.00	4273.70	4997.94	5847.40	5173.86	5500.86
PE Ratio	15.54	15.37	19.80	-	29.83	-
PS Ratio	0.50	0.50	0.66	0.89	0.84	0.94
PB Ratio	0.91	0.90	1.15	1.41	1.43	1.65
P/TBV Ratio	0.92	0.91	1.16	1.43	1.45	1.67
P/FCF Ratio	39.97	39.51	100.14	47.40	20.23	14.65
P/OCF Ratio	15.18	15.01	26.15	33.53	16.32	11.76
EV/Sales Ratio	0.62	0.57	0.79	1.04	1.00	1.20
EV/EBITDA Ratio	11.50	10.62	12.52	63.55	13.03	52.42
EV/EBIT Ratio	17.51	16.16	18.50	-	24.13	-
EV/FCF Ratio	48.85	45.09	120.53	55.65	24.26	18.66
Debt / Equity Ratio	0.31	0.31	0.33	0.36	0.39	0.53
Debt / EBITDA Ratio	3.23	3.23	2.98	13.84	2.93	13.12
Debt / FCF Ratio	13.72	13.72	28.68	12.12	5.45	4.67
Net Debt / Equity Ratio	0.20	0.20	0.23	0.24	0.31	0.41
Net Debt / EBITDA Ratio	2.09	2.09	2.10	9.04	2.36	10.24
Net Debt / FCF Ratio	8.88	8.88	20.17	7.92	4.39	3.65
Asset Turnover	1.01	1.01	0.95	0.90	0.92	0.84
Inventory Turnover	3.40	3.40	3.39	3.14	3.27	3.42
Quick Ratio	0.63	0.63	1.13	0.53	0.54	0.58
Current Ratio	1.09	1.09	2.00	0.92	1.01	0.88
Return on Equity (ROE)	6.09%	6.09%	5.97%	-10.58%	4.97%	-2.24%
Return on Assets (ROA)	2.22%	2.22%	2.55%	-0.83%	2.38%	-0.73%
Return on Invested Capital (ROIC)	4.87%	4.81%	4.90%	-1.97%	4.06%	-1.67%
Return on Capital Employed (ROCE)	5.10%	5.10%	4.90%	-1.90%	5.90%	-2.00%
Earnings Yield	6.43%	6.51%	5.05%	-7.02%	3.35%	-1.38%
FCF Yield	2.50%	2.53%	1.00%	2.11%	4.94%	6.83%
Payout Ratio	10.72%	10.72%	-	-	-	-
Buyback Yield / Dilution	-0.08%	-0.08%	-0.39%	0.03%	0.03%	0.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.